Aim & Scope
Molecular Neurodegeneration is an open access, peer-reviewed journal that encompasses all aspects of neurodegeneration research at the molecular and cellular levels. Neurodegenerative diseases collectively refer to neurological disorders that result from neurodegeneration and include, but are not limited to, Alzheimer's disease, Parkinson's disease, Huntington's disease, and prion diseases. These diseases, which are often associated with advanced aging and display varying degrees of dementia, have become a significant public health issue as humans live longer and the aging population grows larger. Recent advances in the molecular and cellular mechanisms underlying the pathogenesis of these neurodegenerative disorders have allowed for a better understanding of the disease mechanisms. [1]
2024 - VOLUME 19, ISSUE 1
L Wang , NP Nykänen , D Western , ... , C Cruchaga
Molecular Neurodegeneration , 2024 - VOLUME 19, ISSUE 1 , p 1.
4
87
J Therriault , MS Woo , G Salvadó , ... , P Rosa-Neto
Molecular Neurodegeneration , 2024 - VOLUME 19, ISSUE 1 , p 2.
2
43
Blood platelet factor 4: the elixir of brain rejuvenation.
Molecular Neurodegeneration , 2024 - VOLUME 19, ISSUE 1 , p 3.
0
10
G Son , TC Neylan , LT Grinberg
Molecular Neurodegeneration , 2024 - VOLUME 19, ISSUE 1 , p 4.
Review
0
113
Brain clearance of protein aggregates: a close-up on astrocytes.
V Giusti , G Kaur , E Giusto , L Civiero
Molecular Neurodegeneration , 2024 - VOLUME 19, ISSUE 1 , p 5.
Review
4
172
M Calvo-Rodriguez , EK Kharitonova , AC Snyder , ... , BJ Bacskai
Molecular Neurodegeneration , 2024 - VOLUME 19, ISSUE 1 , p 6.
2
97
Unravelling cell type-specific responses to Parkinson's Disease at single cell resolution.
A Martirosyan , R Ansari , F Pestana , ... , MG Holt
Molecular Neurodegeneration , 2024 - VOLUME 19, ISSUE 1 , p 7.
2
69
Nuclear-import receptors as gatekeepers of pathological phase transitions in ALS/FTD.
B Khalil , M Linsenmeier , CL Smith , ... , W Rossoll
Molecular Neurodegeneration , 2024 - VOLUME 19, ISSUE 1 , p 8.
Review
1
312
Fluid biomarkers for amyotrophic lateral sclerosis: a review.
KE Irwin , U Sheth , PC Wong , TF Gendron
Molecular Neurodegeneration , 2024 - VOLUME 19, ISSUE 1 , p 9.
Review
5
169
ML Alosco , M White , C Bell , ... , J Mez
Molecular Neurodegeneration , 2024 - VOLUME 19, ISSUE 1 , p 10.
1
75
Editorial Retractions, Expressions of Concern and External Notices
H Jiao , M Rutar , N Fernando , ... , R Natoli
Molecular Neurodegeneration2018 - VOLUME 13, ISSUE 1 p 45.
32 59
F L'episcopo , MF Serapide , C Tirolo , ... , B Marchetti
Molecular Neurodegeneration2011 - VOLUME 6, ISSUE 1 p 49.
122 94
P Desplats , P Patel , K Kosberg , ... , E Masliah
Molecular Neurodegeneration2012 - VOLUME 7, ISSUE 1 p 49.
38 35
Evaluation of Dimebon in cellular model of Huntington's disease.
J Wu , Q Li , I Bezprozvanny
Molecular Neurodegeneration2008 - VOLUME 3, ISSUE 1 p 15.
54 19
Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
T Koeglsperger , SL Rumpf , P Schließer , ... , J Herms
Molecular Neurodegeneration2023 - VOLUME 18, ISSUE 1 p 32.
14 226
E Acquarone , EK Argyrousi , M van den Berg , ... , J Fiorito
Molecular Neurodegeneration2019 - VOLUME 14, ISSUE 1 p 26.
31 112
H Guo , TM Barrett , Z Zhong , ... , BV Zlokovic
Molecular Neurodegeneration2011 - VOLUME 6, ISSUE 1 p 13.
16 65
M Iba , RA McDevitt , C Kim , ... , E Masliah
Molecular Neurodegeneration2022 - VOLUME 17, ISSUE 1 p 60.
14 88